Effects of green tea extract epigallocatechin-3-gallate (EGCG) on oral disease-associated microbes: a review

References

• Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea–a review. J Am Coll Nutr. 2006 Apr;25(2):79–14.
   PubMed Web of Science ®Google Scholar
• Mak JC. Potential role of green tea catechins in various disease therapies: progress and promise. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):265–273.
   Web of Science ®Google Scholar
• Reygaert WC. The antimicrobial possibilities of green tea. Front Microbiol. 2014 Aug;20(5):434.
   Google Scholar
• Botten D, Fugallo G, Fraternali F, et al. Structural properties of green tea catechins. J Phys Chem B. 2015 Oct 8;119(40):12860–12867.
   Web of Science ®Google Scholar
• Taylor PW, Hamilton-Miller JM, Stapleton PD. Antimicrobial properties of green tea catechins. Food Sci Technol Bulletin. 2005;2:71–81.
   PubMedGoogle Scholar
• Kochman J, Jakubczyk K, Antoniewicz J, et al. Chemical composition of matcha green tea: a review. Molecules. 2020 Dec 27;26(1):85.
   Web of Science ®Google Scholar
• Narotzki B, Reznick AZ, Aizenbud D, et al. Green tea: a promising natural product in oral health. Arch Oral Biol. 2012 May;57(5):429–435.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Feng M, Wan J, et al. Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities. Food Funct. 2021 Oct 19;12(20):9607–9619.
   Web of Science ®Google Scholar
• Mc Naught J. On the action of cold or lukewarm tea on Bacillus typhosus. J R Army Med Corps. 1906;7:372–373.
   Google Scholar
• Steinmann J, Buer J, Pietschmann T, et al. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol. 2013 Mar;168(5):1059–1073.
   PubMed Web of Science ®Google Scholar
• Reygaert WC. Green tea catechins: their use in treating and preventing infectious diseases. Biomed Res Int. 2018 Jul;17(2018):9105261.
   Google Scholar
• Chakrawarti L, Agrawal R, Dang S, et al. Therapeutic effects of EGCG: a patent review. Expert Opin Ther Pat. 2016 Aug;26(8):907–916.
   PubMed Web of Science ®Google Scholar
• Vyas T, Nagi R, Bhatia A, et al. Therapeutic effects of green tea as an antioxidant on oral health- A review. J Family Med Prim Care. 2021 Nov;10(11):3998–4001.
   Google Scholar
• Moraes DE, Passos VF, Padovani GC, Bezerra LCBDR, Vasconcelos IM, Santiago SL, PASSOS VF, PADOVANI GC. Protective effect of green tea catechins on eroded human dentin: an in vitro/in situ study. Braz Oral Res. 2021 Nov;19(35):e108.
   Google Scholar
• Vaillancourt K, Ben Lagha A, Grenier D. A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model. Arch Oral Biol. 2021 Jun;126:105135.
   Web of Science ®Google Scholar
• Gan RY, Li HB, Sui ZQ, et al. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr. 2018 Apr 13;58(6):924–941.
   PubMed Web of Science ®Google Scholar
• Liao S, Tang Y, Chu C, et al. Application of green tea extracts epigallocatechin-3-gallate in dental materials: recent progress and perspectives. J Biomed Mater Res A. 2020 Dec;108(12):2395–2408.
   Web of Science ®Google Scholar
• Araghizadeh A, Kohanteb J, Fani MM. Inhibitory activity of green tea (Camellia sinensis) extract on some clinically isolated cariogenic and periodontopathic bacteria. Med Princ Pract. 2013;22(4):368–372.
   Web of Science ®Google Scholar
• Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017 Apr;23(3):276–286.
   PubMed Web of Science ®Google Scholar
• Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018 May;200(4):525–540.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Li H, et al. Human oral microbiota and its modulation for oral health. Biomed Pharmacother. 2018 Mar;99:883–893.
   PubMed Web of Science ®Google Scholar
• Shivakumar KM, Vidya SK, Chandu GN. Dental caries vaccine. Indian J Dent Res. 2009 Jan-Mar;20(1):99–106.
   Google Scholar
• Ruby JD, Cox CF, Akimoto N, et al. The caries phenomenon: a timeline from witchcraft and superstition to opinions of the 1500s to today’s science. Int J Dent. 2010;2010:432767.
   Google Scholar
• Grigalauskienė R, Slabšinskienė E, Vasiliauskienė I. Biological approach of dental caries management. Stomatologija. 2015;17(4):107–112.
   PubMedGoogle Scholar
• Zhao IS, Yin IX, Mei ML, et al. Remineralising dentine caries using sodium fluoride with silver nanoparticles: an in vitro study. Int J Nanomedicine. 2020;15:2829–2839.
   PubMed Web of Science ®Google Scholar
• Liao Y, Brandt BW, Li J, et al. Fluoride resistance in Streptococcus mutans: a mini review. J Oral Microbiol. 2017 Jul 6;9(1):1344509.
   PubMed Web of Science ®Google Scholar
• Chen F, Wang D. Novel technologies for the prevention and treatment of dental caries: a patent survey. Expert Opin Ther Pat. 2010 May;20(5):681–694.
   PubMed Web of Science ®Google Scholar
• Clarke JK. On the bacterial factor in the aetiology of dental caries. Br J Exp Pathol. 1924;5:141–147.
   Google Scholar
• Islam B, Khan SN, Khan AU. Dental caries: from infection to prevention. Med Sci Monit. 2007 Nov;13(11):RA196–203.
   PubMed Web of Science ®Google Scholar
• Shen S, Samaranayake LP, Yip HK. In vitro growth, acidogenicity and cariogenicity of predominant human root caries flora. J Dent. 2004 Nov;32(8):667–678.
   PubMed Web of Science ®Google Scholar
• Ikigai H, Nakae T, Hara Y, et al. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta. 1993 Apr 8;1147(1):132–136.
   PubMed Web of Science ®Google Scholar
• Bai L, Takagi S, Ando T, et al. Antimicrobial activity of tea catechin against canine oral bacteria and the functional mechanisms. J Vet Med Sci. 2016 Oct 1;78(9):1439–1445.
   Web of Science ®Google Scholar
• Arakawa H, Maeda M, Okubo S, et al. Role of hydrogen peroxide in bactericidal action of catechin. Biol Pharm Bull. 2004 Mar;27(3):277–281.
   PubMed Web of Science ®Google Scholar
• Wu M, Brown AC. Applications of catechins in the treatment of bacterial infections. Pathogens. 2021 May 1;10(5):546.
   Web of Science ®Google Scholar
• Xu X, Zhou XD, Wu CD. The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrob Agents Chemother. 2011 Mar;55(3):1229–1236.
   PubMed Web of Science ®Google Scholar
• Han S, Abiko Y, Washio J, et al. Green tea-derived epigallocatechin gallate inhibits acid production and promotes the aggregation of streptococcus mutans and non-mutans streptococci. Caries Res. 2021;55(3):205–214.
   Web of Science ®Google Scholar
• Senpuku H, Tuna EB, Nagasawa R, et al. The inhibitory effects of polypyrrole on the biofilm formation of Streptococcus mutans. PLoS One. 2019 Nov 27;14(11):e0225584.
   PubMed Web of Science ®Google Scholar
• Liu BH, Yu LC. In-situ, time-lapse study of extracellular polymeric substance discharge in Streptococcus mutans biofilm. Colloids Surf B Biointerfaces. 2017 Feb;1(150):98–105.
   Google Scholar
• Wu CY, Su TY, Wang MY, et al. Inhibitory effects of tea catechin epigallocatechin-3-gallate against biofilms formed from Streptococcus mutans and a probiotic lactobacillus strain. Arch Oral Biol. 2018 Oct;94:69–77.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhou XD, Wu CD. Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes. Arch Oral Biol. 2012 Jun;57(6):678–683.
   Web of Science ®Google Scholar
• Schneider-Rayman M, Steinberg D, Sionov RV, et al. Effect of epigallocatechin gallate on dental biofilm of Streptococcus mutans: an in vitro study. BMC Oral Health. 2021 Sep 15;21(1):447.
   Web of Science ®Google Scholar
• Vilela MM, Salvador SL, Teixeira IGL, et al. Efficacy of green tea and its extract, epigallocatechin-3-gallate, in the reduction of cariogenic microbiota in children: a randomized clinical trial. Arch Oral Biol. 2020 Jun;114:104727.
   Web of Science ®Google Scholar
• Theilade E. Advances in oral microbiology. Ann R Australas Coll Dent Surg. 1989;Oct;10:62–71.
   Google Scholar
• Svec P, Kukletová M, Sedlácek I. Comparative evaluation of automated ribotyping and RAPD-PCR for typing of Lactobacillus spp. occurring in dental caries. Antonie Van Leeuwenhoek. 2010 Jun;98(1):85–92.
   PubMed Web of Science ®Google Scholar
• Badet C, Richard B, Castaing-Debat M, et al. Adaptation of salivary Lactobacillus strains to xylitol. Arch Oral Biol. 2004 Feb;49(2):161–164.
   Web of Science ®Google Scholar
• Wen ZT, Yates D, Ahn SJ, et al. Biofilm formation and virulence expression by Streptococcus mutans are altered when grown in dual-species model. BMC Microbiol. 2010 Apr;14(10):111.
   Google Scholar
• Byun R, Nadkarni MA, Chhour KL, et al. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol. 2004 Jul;42(7):3128–3136.
   PubMed Web of Science ®Google Scholar
• de Soet JJ, de Graaff J. Microbiology of carious lesions. Dent Update. 1998 Oct;25(8):319–324.
   Google Scholar
• Ferrazzano GF, Roberto L, Amato I, et al. Antimicrobial properties of green tea extract against cariogenic microflora: an in vivo study. J Med Food. 2011 Sep;14(9):907–911.
   Web of Science ®Google Scholar
• Hegde RJ, Kamath S. Comparison of the Streptococcus mutans and Lactobacillus colony count changes in saliva following chlorhexidine (0.12%) mouth rinse, combination mouth rinse, and green tea extract (0.5%) mouth rinse in children. J Indian Soc Pedod Prev Dent. 2017 Apr-Jun;35(2):150–155.
   Google Scholar
• Thomas A, Thakur SR, Shetty SB. Anti-microbial efficacy of green tea and chlorhexidine mouth rinses against Streptococcus mutans, Lactobacilli spp and Candida albicans in children with severe early childhood caries: a randomized clinical study. J Indian Soc Pedod Prev Dent. 2016 Jan-Mar;34(1):65–70.
   Google Scholar
• Anita P, Sivasamy S, Madan Kumar PD, et al. In vitro antibacterial activity of Camellia sinensis extract against cariogenic microorganisms. J Basic Clin Pharm. 2014 Dec;6(1):35–39.
   Google Scholar
• Huang ZW, Zhou XD, Xiao Y, et al. In vitro study of the effect of 11 kinds of natural drugs on the growth and acid production of Lactobacillus. Shanghai Kou Qiang Yi Xue. 2005 Feb;14(1):67–70.
   PubMedGoogle Scholar
• Xiao Y, Liu T, Zhan L, et al. The effects of tea polyphenols on the adherence of cariogenic bacterium to the collagen in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 2000 Oct;18(5):340–342.
   Google Scholar
• Kõll-Klais P, Mändar R, Leibur E, et al. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol. 2005 Dec;20(6):354–361.
   Google Scholar
• Nishihara T, Suzuki N, Yoneda M, et al. Effects of Lactobacillus salivarius-containing tablets on caries risk factors: a randomized open-label clinical trial. BMC Oral Health. 2014 Sep;2(14):110.
   Google Scholar
• Kõll P, Mändar R, Marcotte H, et al. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol Immunol. 2008 Apr;23(2):139–147.
   PubMedGoogle Scholar
• Näse L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001 Nov-Dec;35(6):412–420.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu XL, Sun YK, et al. Fermentation in vitro of EGCG, GCG and EGCG3 “ Me isolated from Oolong tea by human intestinal microbiota. Food Res Int. 2013;54(2):1589–1595.
   Web of Science ®Google Scholar
• Sourabh A, Kanwar SS, Sud RG, et al. Influence of phenolic compounds of Kangra tea [Camellia sinensis (L) O Kuntze] on bacterial pathogens and indigenous bacterial probiotics of Western Himalayas. Braz J Microbiol. 2014 Jan 15;44(3):709–715.
   Web of Science ®Google Scholar
• Story EN, Azcarate-Peril A, Klaenhammer TR, et al. Effect of green tea and EGCG on the growth rate and cell density of the probiotic bacteria Lactobacillus acidophilus and Lactobacillus gasseri. Faseb J. 2009;23(S1):1.
   Google Scholar
• Higuchi T, Suzuki N, Nakaya S, et al. Effects of Lactobacillus salivarius WB21 combined with green tea catechins on dental caries, periodontitis, and oral malodor. Arch Oral Biol. 2019 Feb;98:243–247.
   Web of Science ®Google Scholar
• Bowden GH. Microbiology of root surface caries in humans. J Dent Res. 1990 May;69(5):1205–1210.
   Web of Science ®Google Scholar
• Liu T, Gibbons RJ, Hay DI, et al. Binding of Actinomyces viscosus to collagen: association with the type 1 fimbrial adhesin. Oral Microbiol Immunol. 1991;6(1):1–5.
   Google Scholar
• Wang Y, Samaranayake LP, Dykes GA. Plant components affect bacterial biofilms development by altering their cell surface physicochemical properties: a predictability study using Actinomyces naeslundii. FEMS Microbiol Ecol. 2020 Dec 29;97(1):fiaa217.
   Web of Science ®Google Scholar
• Abdulbaqi HR, Himratul-Aznita WH, Baharuddin NA. Anti-plaque effect of a synergistic combination of green tea and Salvadora persica Lagainst primary colonizers of dental plaque. Arch Oral Biol. 2016 Oct;70:117–124.
   Web of Science ®Google Scholar
• Xiao Y, Liu T, Huang Z, et al. The in vitro study of the effects of 11 kinds of traditional Chinese medicine on the growth and acid production of Actinomyces viscosus. Hua Xi Yi Ke Da Xue Xue Bao. 2002 Apr;33(2):253–255.
   Google Scholar
• Wang Y, Lam ATW. Epigallocatechin gallate and gallic acid affect colonization of abiotic surfaces by oral bacteria. Arch Oral Biol. 2020 Dec;120:104922.
   Web of Science ®Google Scholar
• Wang Y, Chung FF, Lee SM, et al. Inhibition of attachment of oral bacteria to immortalized human gingival fibroblasts (HGF-1) by tea extracts and tea components. BMC Res Notes. 2013 Apr 11;6(1):143.
   Google Scholar
• Xu X, Chen F, Huang Z, et al. Meeting report: a close look at oral biofilms and microbiomes. Int J Oral Sci. 2018 Aug 15;10(3):28.
   Google Scholar
• Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019 Nov 5;11(3):30.
   PubMed Web of Science ®Google Scholar
• Drisko CH. Nonsurgical periodontal therapy. Periodontol 2000. 2001;25(1):77–88.
   Google Scholar
• Matsubara VH, Bandara HM, Ishikawa KH, et al. The role of probiotic bacteria in managing periodontal disease: a systematic review. Expert Rev Anti Infect Ther. 2016 Jul;14(7):643–655.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011 Nov 17;10(5):497–506.
   PubMed Web of Science ®Google Scholar
• Berezow AB, Darveau RP. Microbial shift and periodontitis. Periodontol 2000. 2011 Feb;55(1):36–47.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett. 2012 Aug;333(1):1–9.
   PubMed Web of Science ®Google Scholar
• Śmiga M, Smalley JW, Ślęzak P, et al. Glycation of host proteins increases pathogenic potential of porphyromonas gingivalis. Int J Mol Sci. 2021 Nov 8;22(21):12084.
   Web of Science ®Google Scholar
• Cai Y, Chen Z, Liu H, et al. Green tea epigallocatechin-3-gallate alleviates Porphyromonas gingivalis-induced periodontitis in mice. Int Immunopharmacol. 2015 Dec;29(2):839–845.
   Web of Science ®Google Scholar
• Asahi Y, Noiri Y, Miura J, et al. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms. J Appl Microbiol. 2014 May;116(5):1164–1171.
   Web of Science ®Google Scholar
• Xu X, Zhou XD, Wu CD. Tea catechin EGCg suppresses the mgl gene associated with halitosis. J Dent Res. 2010 Nov;89(11):1304–1308.
   Web of Science ®Google Scholar
• Hočevar K, Potempa J, Turk B. Host cell-surface proteins as substrates of gingipains, the main proteases of Porphyromonas gingivalis. Biol Chem. 2018 Nov 27;399(12):1353–1361.
   Web of Science ®Google Scholar
• Guo Y, Nguyen KA, Potempa J. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon’s knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000. 2010 Oct;54(1):15–44.
   PubMedGoogle Scholar
• Fitzpatrick RE, Wijeyewickrema LC, Pike RN. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol. 2009 May;4(4):471–487.
   Web of Science ®Google Scholar
• Okamoto M, Sugimoto A, Leung KP, et al. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol. 2004 Apr;19(2):118–120.
   PubMedGoogle Scholar
• Sakanaka S, Aizawa M, Kim M, et al. Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem. 1996 May;60(5):745–749.
   Web of Science ®Google Scholar
• Sakanaka S, Okada Y. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J Agric Food Chem. 2004 Mar 24;52(6):1688–1692.
   Web of Science ®Google Scholar
• Osawa K, Matsumoto T, Yasuda H, et al. The inhibitory effect of plant extracts on the collagenolytic activity and cytotoxicity of human gingival fibroblasts by Porphyromonas gingivalis crude enzyme. Bull Tokyo Dent Coll. 1991 Feb;32(1):1–7.
   PubMedGoogle Scholar
• Makimura M, Hirasawa M, Kobayashi K, et al. Inhibitory effect of tea catechins on collagenase activity. J Periodontol. 1993 Jul;64(7):630–636.
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998 Dec;62(4):1244–1263.
   PubMed Web of Science ®Google Scholar
• Amano A, Nakagawa I, Okahashi N, et al. Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J Periodontal Res. 2004 Apr;39(2):136–142.
   Web of Science ®Google Scholar
• Belton CM, Izutsu KT, Goodwin PC, et al. Fluorescence image analysis of the association between Porphyromonas gingivalis and gingival epithelial cells. Cell Microbiol. 1999 Nov;1(3):215–223.
   PubMed Web of Science ®Google Scholar
• Yilmaz O, Watanabe K, Lamont RJ. Involvement of integrins in fimbriae-mediated binding and invasion by Porphyromonas gingivalis. Cell Microbiol. 2002 May;4(5):305–314.
   PubMed Web of Science ®Google Scholar
• Ö Y, Young PA, Lamont RJ, et al. Gingival epithelial cell signalling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology (Reading). 2003 Sep;149(Pt 9):2417–2426.
   Google Scholar
• Fournier-Larente J, Morin MP, Grenier D. Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis. Arch Oral Biol. 2016 May;65:35–43.
   PubMed Web of Science ®Google Scholar
• Yuan L, Rodrigues PH, Bélanger M, et al. Porphyromonas gingivalis htrA is involved in cellular invasion and in vivo survival. Microbiology (Reading). 2008 Apr;154(Pt 4):1161–1169.
   Google Scholar
• Kato S, Kowashi Y, Demuth DR. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog. 2002 Jan;32(1):1–13.
   Web of Science ®Google Scholar
• Vega BA, Belinka BA Jr, Kachlany SC. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera®): mechanisms of action and therapeutic applications. Toxins (Basel). 2019 Aug 26;11(9):489.
   Web of Science ®Google Scholar
• Nice JB, Balashova NV, Kachlany SC, et al. Aggregatibacter actinomycetemcomitans leukotoxin is delivered to host cells in an LFA-1-indepdendent manner when associated with outer membrane vesicles. Toxins (Basel). 2018 Oct 13;10(10):414.
   Web of Science ®Google Scholar
• Nakamura K, Ishiyama K, Sheng H, et al. Bactericidal activity and mechanism of photoirradiated polyphenols against gram-positive and -negative bacteria. J Agric Food Chem. 2015 Sep 9;63(35):7707–7713.
   PubMed Web of Science ®Google Scholar
• Hara K, Ohara M, Hayashi I, et al. The green tea polyphenol (-)-epigallocatechin gallate precipitates salivary proteins including alpha-amylase: biochemical implications for oral health. Eur J Oral Sci. 2012 Apr;120(2):132–139.
   Web of Science ®Google Scholar
• Kawashima Y. Effects of catechin gallate on bactericidal action and leukotoxic activity of aggregatibacter actinomycetemcomitans. Int J Oral Med Sci. 2011;10(1):20–24
   Google Scholar
• Saito M, Tsuzukibashi O, Takada K. Anticytotoxic effect of green tea catechin on aggregatibacter actinomycetemcomitans vesicles. Int J Oral Med Sci. 2012;11(2):101–105
   Google Scholar
• Chang EH, Huang J, Lin Z, et al. Catechin-mediated restructuring of a bacterial toxin inhibits activity. Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):191–198.
   PubMed Web of Science ®Google Scholar
• Webb JN, Koufos E, Brown AC. Inhibition of bacterial toxin activity by the nuclear stain, DRAQ5™. J Membr Biol. 2016 Aug;249(4):503–511.
   Web of Science ®Google Scholar
• Chang EH, Giaquinto P, Huang J, et al. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane. Mol Oral Microbiol. 2020 Jan;35(1):29–39.
   Web of Science ®Google Scholar
• Chang EH, Brown AC. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence. J Pharm Pharmacol. 2021 Mar 8;73(4):505–514.
   Web of Science ®Google Scholar
• Bielecki M, Antonyuk S, Strange RW, et al. Prevotella intermedia produces two proteins homologous to Porphyromonas gingivalis HmuY but with different heme coordination mode. Biochem J. 2020 Jan 31;477(2):381–405.
   PubMed Web of Science ®Google Scholar
• Hirasawa M, Takada K, Makimura M, et al. Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. J Periodontal Res. 2002 Dec;37(6):433–438.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Leung KP, Ansai T, et al. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol Immunol. 2003 Jun;18(3):192–195.
   Google Scholar
• Duque C, Dos Santos VR, Abuna GF. Cytocompatibility and synergy of EGCG and cationic peptides against bacteria related to endodontic infections, in planktonic and biofilm conditions. Probiotics Antimicrob Proteins. 2021 Dec;13(6):1808–1819.
   Web of Science ®Google Scholar
• Bolstad AI, Jensen HB, Bakken V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev. 1996 Jan;9(1):55–71.
   PubMed Web of Science ®Google Scholar
• Shahzad M, Millhouse E, Culshaw S, et al. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation. Food Funct. 2015 Mar;6(3):719–729.
   PubMed Web of Science ®Google Scholar
• Ben Lagha A, Haas B, Grenier D. Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum. Sci Rep. 2017 Mar;21(7):44815.
   Google Scholar
• Nobile CJ, Johnson AD. Candida albicans biofilms and human disease. Annu Rev Microbiol. 2015;69(1):71–92.
   PubMedGoogle Scholar
• Nivoix Y, Ledoux MP, Herbrecht R. Antifungal therapy:new and evolving therapies. Semin Respir Crit Care Med. 2020 Feb;41(1):158–174.
   PubMed Web of Science ®Google Scholar
• Park BJ, Park JC, Taguchi H, et al. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun. 2006 Aug 25;347(2):401–405.
   Web of Science ®Google Scholar
• Chen M, Zhai L, Arendrup MC. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species. Med Mycol. 2015 Feb 1;53(2):194–198.
   PubMed Web of Science ®Google Scholar
• Hirasawa M, Takada K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J Antimicrob Chemother. 2004 Feb;53(2):225–229.
   PubMed Web of Science ®Google Scholar
• Navarro-Martínez MD, García-Cánovas F, Rodríguez-López JN. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J Antimicrob Chemother. 2006 Jun;57(6):1083–1092.
   Web of Science ®Google Scholar
• Behbehani JM, Irshad M, Shreaz S, et al. Synergistic effects of tea polyphenol epigallocatechin 3-O-gallate and azole drugs against oral Candida isolates. J Mycol Med. 2019 Jun;29(2):158–167.
   Web of Science ®Google Scholar
• Evensen NA, Braun PC. The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation. Can J Microbiol. 2009 Sep;55(9):1033–1039.
   PubMed Web of Science ®Google Scholar
• Han Y. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol Pharm Bull. 2007 Sep;30(9):1693–1696.
   Web of Science ®Google Scholar
• Ning Y, Ling J, Wu CD. Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species. Arch Oral Biol. 2015 Oct;60(10):1565–1570.
   Web of Science ®Google Scholar
• da Silva CR, de Andrade Neto JB, de Sousa Campos R, et al. Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother. 2014;58(3):1468–1478.
   PubMed Web of Science ®Google Scholar
• Yakin M, Seo B, Hussaini H, et al. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials. Aust Dent J. 2019 Mar;64(1):11–18.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li X, Song S, et al. Integrity of a HPV11 infection cell model and identification of (-)-Epigallocatechin-3-gallate as a potential HPV11 inhibitor. Oncotarget. 2016 Jun 14;7(24):37092–37102.
   Google Scholar
• Song JY, Han JH, Song Y, et al. Epigallocatechin-3-gallate can prevent type 2 human papillomavirus E7 from suppressing interferon-stimulated genes. Int J Mol Sci. 2021 Feb 28;22(5):2418.
   Web of Science ®Google Scholar
• Yap JKW, Kehoe ST, Woodman CBJ, et al. The major constituent of green tea, epigallocatechin-3-Gallate (EGCG), inhibits the growth of HPV18-infected keratinocytes by stimulating proteasomal turnover of the E6 and E7 oncoproteins. Pathogens. 2021 Apr 11;10(4):459.
   Web of Science ®Google Scholar
• Wang YQ, Lu JL, Liang YR, et al. Suppressive effects of EGCG on cervical cancer. Molecules. 2018 Sep 12;23(9):2334.
   PubMed Web of Science ®Google Scholar
• Bacon TH, Levin MJ, Leary JJ, et al. Herpes simplex virus resistance to Acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev. 2003 Jan;16(1):114–128.
   PubMed Web of Science ®Google Scholar
• Pradhan P, Nguyen ML. Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate. Virus Res. 2018 Apr 2;249:93–98.
   Web of Science ®Google Scholar
• Isaacs CE, Wen GY, Xu W, et al. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob Agents Chemother. 2008 Mar;52(3):962–970.
   PubMed Web of Science ®Google Scholar
• Colpitts CC, Schang LM, Hutt-Fletcher L. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J Virol. 2014 Jul;88(14):7806–7817.
   PubMed Web of Science ®Google Scholar
• Wu CY, Yu ZY, Chen YC, et al. Effects of epigallocatechin-3-gallate and Acyclovir on herpes simplex virus type 1 infection in oral epithelial cells. J Formos Med Assoc. 2021 Dec;120(12):2136–2143.
   Web of Science ®Google Scholar
• Qiu X, Zhong M, Xiang Y, et al. Self-organizing maps for the classification of gallic acylate polyphenols as HSV-1 inhibitors. Med Chem. 2014 Jun;10(4):388–401.
   Web of Science ®Google Scholar
• Huo C, Wan SB, Lam WH, et al. The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology. 2008 Oct;16(5):248–252.
   PubMedGoogle Scholar
• Mazzanti G, Di Sotto A, Vitalone A. Hepatotoxicity of green tea: an update. Arch Toxicol. 2015 Aug;89(8):1175–1191.
   PubMed Web of Science ®Google Scholar
• Kucera O, Mezera V, Moravcova A, et al. In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes. Oxid Med Cell Longev. 2015;2015:476180.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Kaihatsu K, Nishino K, et al. Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate. Front Microbiol. 2012 Feb;16(3):53.
   Google Scholar
• Xu X, Dai Z, Zhang Z, et al. Fabrication of oral nanovesicle in-situ gel based on Epigallocatechin gallate phospholipid complex: application in dental anti-caries. Eur J Pharmacol. 2021 Apr;15(897):173951.
   Google Scholar
• Hu J, Du X, Huang C, et al. Antibacterial and physical properties of EGCG-containing glass ionomer cements. J Dent. 2013 Oct;41(10):927–934.
   PubMed Web of Science ®Google Scholar